Showing results (1021-1030 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 14, 2026
Novel Tetrahydroquinazoline Derivatives for Treating HIV Infection or AIDS or AIDS Related ComplexRam W SabnisACS Medicinal Chemistry Letters|July 14, 2026
The Great Potential of the Cluster of Differentiation 38 (CD38) Inhibitors in the Treatment of Cancer and Age-Related Metabolic dysfunctionAhmed F Abdel-MagidACS Medicinal Chemistry Letters|July 14, 2026
Novel Compounds as Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic RetinopathyRam W SabnisACS Medicinal Chemistry Letters|July 14, 2026
Cefpiramide Restricts Mycobacterium tuberculosis Growth by Binding to the DNA-Binding Domain of an Essential Response Regulator, MtrASiranjeevi Rangaraj, Shalini Saxena, Vidya Chitta Voina, et al.ACS Medicinal Chemistry Letters|July 14, 2026
Discovery of NKT2152, a Potent and Selective HIF-2α Inhibitor with Favorable Pharmacokinetic PropertiesJiping Fu, Yigang He, Jing Lu, et al.ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Selective AMPK Activator That Inhibits de Novo LipogenesisJorge E Gómez-Galeno, Qun Dang, Thanh H Nguyen, et al.ACS Medicinal Chemistry Letters|August 20, 2026
Identification and Studies of Highly Potent and Selective Heterobifunctional Galectin‑3 DegradersChunjian Liu, Wei Wang, Aaron J Balog, et al.ACS Medicinal Chemistry Letters|August 20, 2026
Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS DisordersRam W Sabnis, Anika R SabnisACS Medicinal Chemistry Letters|August 20, 2026
Design, Synthesis, and Evaluation of Diphenylpyrazinyl Amino Cycloalkoxy Acetic Acids as IP Receptor AgonistsXianrong Cai, Minhui Dai, Yuhe Wang, et al.ACS Medicinal Chemistry Letters|August 20, 2026
Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung CancerRam W SabnisPageof 438